Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency, Chronic × empagliflozin × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

peginesatide 1 hematide 1 finerenone 1 empagliflozin 1 Standard of Care 1 Rocuronium 1 Practice Guidelines as Topic 1 Polymorphism, Genetic 1 Hypothermia, Induced 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06818305 2025-12-11

EmFin-Nx

Jinling Hospital, China

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡